IQVIA Holdings (IQV) Stock Forecast & Price Prediction

Estimation of the future price movement of IQVIA Holdings stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $251.74

Concensus $277.18


Low $235.00

Median $275.00

High $320.00

Based on analysts projections #IQV is expected to experience a positive growth trajectory over the next year.

The current average IQV price target, as estimated by these analysts, is $277.18.

The predictions for the future IQV stock price range from a low of $235.00 to a high of $320.00, highlighting the variability of market expectations for IQV.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

IQV stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Elizabeth Anderson
Evercore ISI
August 2, 2022 Buy 275.00 236.28
Jeff Garro
Piper Sandler
May 12, 2022 Buy 255.00 202.53
Wells Fargo April 25, 2022 Sell 235.00 228.16
Elizabeth Anderson CFA
Evercore ISI
November 19, 2021 Buy 320.00 268.17
Derik De Bruin
Bank of America Securities
November 17, 2021 Buy 320.00 264.45
Donald Hooker
KeyBanc
November 17, 2021 Buy 290.00 264.45
Patrick B Donnelly
Citigroup
November 17, 2021 Buy 320.00 264.45
Dan Leonard
Wells Fargo
October 22, 2021 Buy 300.00 256.89
Jasper Hellweg
Argus Research
September 10, 2021 Buy 290.00 260.50
Katie Tryhane
Credit Suisse
August 4, 2021 Buy 272.00 249.86
Sandy Draper
Guggenheim
July 28, 2021 Buy 267.00 245.37
Daniel Brennan
Cowen & Co.
April 23, 2021 Buy 275.00 232.30
Scott Schoenhaus
Stephens
April 16, 2021 Sell 250.00 215.56

IQVIA Holdings (IQV) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if IQVIA Holdings is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Strong Buy

Financial Scores

Updated on: 04/03/2024

Altman Z-Score: 2.4

Piotroski Score: 5.0

ESG Score

Updated on: 04/03/2024

Environmental: 64.9

Social: 54.2

Governance: 58.0

Financial Health

Updated on: 04/03/2024

DCF: Neutral

ROE: Buy

ROA: Strong Buy

Debt to equity ratio: Strong Buy

Price to earnings ratio: Strong Buy

Price to book ratio: Strong Buy

IQV Discounted Cash Flow

Updated on: 04/03/2024

$258.876
Discounted Cash Flow Value


$251.735
Current Price

IQV Revenues by Segment

Updated on: 04/03/2024

Contract Sales And Medical Solutions
$7,270,000.00
Research And Development Solutions
$83,950,000.00
Technology And Analytics Solutions
$58,620,000.00

Revenue from Contract with Customer, Excluding Assessed Tax

IQV Revenues by Region

Updated on: 04/03/2024

Americas
$75,520,000.00
Asia Pacific
$29,730,000.00
EMEA
$44,590,000.00

IQV Notes Due

Updated on: 04/03/2024

CIKExchangeTitle

There are no data to display

IQVIA Holdings (IQV) Social Sentiments

Monitoring bullish and bearish sentiments towards IQVIA Holdings on Twitter and Stocktwits could help to forecast an upward or downward trend in IQVIA Holdings stock price.

No social results for IQV

Positive Stock Forecast for IQVIA Holdings: Leading the Way in Diagnostics & Research

IQVIA Holdings (IQV) is a leader in the Diagnostics & Research sector, providing integrated information and technology solutions to the healthcare industry. With a market cap of over $30 billion, IQVIA operates in more than 100 countries and employs more than 68,000 professionals globally. As one of the leading players in this industry, IQVIA has consistently demonstrated its ability to... Read more

Stock Prediction: IQVIA Holdings Leading the Way in Diagnostics & Research Sector

The Diagnostics & Research sector of the stock market is a constantly evolving area that deals with companies focused on healthcare and life sciences. These companies provide an array of services such as diagnostic testing, pharmaceuticals development, clinical trials, and research. One of the major players in this sector is IQVIA Holdings Inc., which has a stock ticker symbol of...
IQVIA Holdings Inc. is one of the largest providers of analytics and data-driven solutions for healthcare organizations around the world. The company's innovative offerings span the entire lifecycle of drug development from discovery to commercialization. Over the years, IQVIA has built an unparalleled reputation in helping clients bring their products to market faster and more efficiently.

In terms of stock predictions for IQVIA Holdings, there is much optimism in this area due to its strong position in the sector. The company's focus on data analytics and technology has helped it maintain its leadership position in an increasingly competitive marketplace. According to analysts, IQVIA Holdings continues to demonstrate steady growth with its impressive financial results.

Investors should keep an eye out for trends in pharmaceuticals industry growth, as this could have a positive impact on IQVIA's performance. Additionally, any major mergers or acquisitions within the Diagnostics & Research sector could potentially benefit IQVIA as well.

In conclusion, with a solid track record and reputation for excellence, IQVIA Holdings stands out among other companies in this sector as a stable investment option for those looking to invest in healthcare and life sciences stocks. As always though, investors need to be cautious when making any kind of investment decisions regardless of how optimistic they may be about a particular stock.

By keeping track of recent trends in the Diagnostics & Research sector and analyzing potential risks related to changes within the wider global markets like geopolitical factors, fluctuations in currency exchange rates etc) will surely help investors make wiser investment decisions in the long run.">Read more